Patents
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
03/2001
03/06/2001US6197294 Cells containing recombinant polynucleotides coding for cell surface molecules that, when expressed in the cell, result in rejection of the cell by host cell by host immune system; useful for gene therapy
03/06/2001US6197293 Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof
03/06/2001US6197229 Primary emulsion is formed which optionally contains a dna nicking inhibitor in addition to dna with or without buffer, temperature of the primary emulsion is lowered below the freezing point of the aqueous inner phase
03/06/2001US6197069 Adrenomedullin receptor polynucleotides
03/01/2001WO2001014581A2 Hdac4 and hdac5 in the regulation of cardiac gene expression
03/01/2001WO2001014579A2 Compositions and methods for delivery of an agent using attenuated salmonella containing phage
03/01/2001WO2001014564A2 Polynucleotides expressed in activated t-lymphocytes and proteins encoded thereby
03/01/2001WO2001014555A1 Human narcolepsy gene
03/01/2001WO2001014554A1 G protein-coupled receptor expressed in brain
03/01/2001WO2001014551A1 NOVEL bHLH TYPE TRANSCRIPTION FACTOR GENE DEC2
03/01/2001WO2001014549A1 Gas1 polypeptides
03/01/2001WO2001014546A2 Replication protein a binding transcriptional factor (rbt1) and uses thereof
03/01/2001WO2001014545A1 Pgrp-l polynucleotides, polypeptides, and antibodies
03/01/2001WO2001014536A2 Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence
03/01/2001WO2001014535A2 UDP-N-ACETYLGLUCOSAMINE: GALACTOSE-β1,3-N-ACETYLGALACTOSAMINE-α-R/(GlcNAc to GalNAc) β1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE, C2GnT3
03/01/2001WO2001014530A2 Method for growing stem cells
03/01/2001WO2001014523A1 TktA
03/01/2001WO2001014418A2 p193 PROTEINS AND NUCLEIC ACIDS, AND USES THEREOF
03/01/2001WO2001014416A2 Synthetic papillomavirus genes optimized for expression in human cells
03/01/2001WO2001014415A2 Egfh2 genes and gene products
03/01/2001WO2001014414A2 Human abc2 transporter and uses thereof
03/01/2001WO2001014402A1 Antisense modulation of focal adhesion kinase expression
03/01/2001WO2001014400A1 2'-o-acetamido modified monomers and oligomers
03/01/2001WO2001014387A1 28-epirapalogs
03/01/2001WO2001013960A1 Methods for in vivo gene delivery to sites of cartilage damage
03/01/2001WO2001013959A1 Method for knocking out gene expression by covalently binding antisense probes
03/01/2001WO2001013951A1 Chondrogenesis promoters
03/01/2001WO2001013723A1 Charge reversal of polyion complexes
03/01/2001WO2001013714A2 Prostatic cell line and animal model of a prostatic tumor
03/01/2001WO2000078948A3 Cloning, expression and characterisation of a cdna coding for a rat brain gamma-hydroxybutyrate (ghb) receptor
03/01/2001WO2000075365A3 COMPOUNDS AND METHODS TO ENHANCE rAAV TRANSDUCTION
03/01/2001WO2000073449B1 Dna encoding snorf33 receptor
03/01/2001WO2000072885A9 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
03/01/2001WO2000071081A3 Methods of diagnosis and treatment of meniere disease
03/01/2001WO2000066619A3 Means and methods for altering the functional properties in eukaryotic cells
03/01/2001WO2000065060A3 Dna sequence and recombinant production of a graminae allergen
03/01/2001WO2000065056A3 NUCLEIC ACIDS ENCODING A mutT DOMAIN-CONTAINING POLYPEPTIDE
03/01/2001WO2000061141A3 Methods and compositions for enhancing delivery of therapeutic agents to tissues
03/01/2001WO2000049168A3 Helper adenovirus / helper-dependent adenovirus vector system based on site-specific recombinase activity
03/01/2001WO2000049162A8 Compositions and methods for non-targeted activation of endogenous genes
03/01/2001WO2000049038A3 Synthetic peptide of regulatory virus protein r (vpr) of human immunodeficiency virus type 1 (hiv-1) and the utilization thereof
03/01/2001WO2000029582A8 Cell surface receptor antigen vaccines
03/01/2001WO1999040214A8 Nucleic acid delivery vehicles
03/01/2001DE19941186A1 Sequenz-spezifische DNA-Rekombination in eukaryotischen Zellen Sequence-specific DNA recombination in eukaryotic cells
03/01/2001CA2383451A1 28-epirapalogs
03/01/2001CA2383371A1 P193 proteins and nucleic acids, and uses thereof
03/01/2001CA2383063A1 Human abc2 transporter and uses thereof
03/01/2001CA2382939A1 Method for growing stem cells
03/01/2001CA2382674A1 Gas1 polypeptides
03/01/2001CA2382204A1 Prostatic cell line and use thereof to obtain an established prostatic cancer in an animal
03/01/2001CA2382146A1 Pgrp-l polynucleotides, polypeptides, and antibodies
03/01/2001CA2382123A1 Novel polynucleotides expressed in activated t-lymphocytes and proteins encoded thereby
03/01/2001CA2382045A1 Hdac4 and hdac5 in the regulation of cardiac gene expression
03/01/2001CA2381991A1 Synthetic human papillomavirus genes
03/01/2001CA2381755A1 Compositions and methods for delivery of an agent using attenuated salmonella containing phage
03/01/2001CA2377730A1 Replication protein a binding transcriptional factor (rbt1) and uses thereof
03/01/2001CA2376505A1 Human narcolepsy gene
03/01/2001CA2376406A1 G protein-coupled receptor expressed in brain
03/01/2001CA2304453A1 Use of ec-sod for treatment of systemic autoimmune diseases
02/2001
02/28/2001EP1078639A1 Stable gene preparations
02/28/2001EP1078267A1 Assays, methods and means for modulating e2f activity
02/28/2001EP1078093A1 Vaccines, immunotherapeutics and methods for using the same
02/28/2001EP1078091A2 Gene therapy vectors and their use in antitumour therapy
02/28/2001EP1078079A1 Methods of forming protein-linked lipidic microparticles, and compositions thereof
02/28/2001EP1078077A1 Nucleic acids and proteins from pineapple stem
02/28/2001EP1078076A2 Novel nucleic acids and polypeptides related to a farnesyl-directed endopeptidase
02/28/2001EP1078075A2 Recombinant (alpha)-l-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
02/28/2001EP1078063A2 Basb029polynucleotide(s) and polypeptides from neisseria meningitis
02/28/2001EP1078062A2 Growth-associated protease inhibitor heavy chain precursor
02/28/2001EP1078060A2 Antibodies to dendritic cells and human dendritic cell populations and uses thereof
02/28/2001EP1078048A2 Transgenic animals produced by homologous sequence targeting
02/28/2001EP1078000A2 Peptides
02/28/2001EP1077996A1 HUMAN EDG3sb GENE
02/28/2001EP1077991A1 Secreted proteins and polynucleotides encoding them
02/28/2001EP1077728A1 Protection from ionizing irradiation or chemotherapeutic drug damage by in vivo gene therapy
02/28/2001EP0769902A4 Methods for reducing hyperacute rejection of xenografts
02/28/2001CN1285845A VEGI, an inhibitor of angiogenesis and tumor growth
02/28/2001CN1062602C Gene of Chinese Strain herpes simplex virus thymidine knase, and application of same
02/27/2001US6194547 ETS2 repressor factor (ERF)
02/27/2001US6194389 Particle-mediated bombardment of DNA sequences into tissue to induce an immune response
02/27/2001US6194388 Immunomodulatory oligonucleotides
02/27/2001US6194212 Increasing gene expression by transducing eukaryotic cells with retrovirus vector having heterologous gene linked to regulatory sequence and scaffold attachment region of human interferon-beta gene, allowing cells to rest and express gene
02/27/2001US6194206 Use of oligonucleotide telomerase inhibitors to reduce telomere length
02/27/2001US6194191 Method for the production and purification of adenoviral vectors
02/27/2001US6194187 Apoptosis-inducing protein and gene encoding the same
02/27/2001US6194176 Recombinant expression of proteins from secretory cell lines
02/27/2001US6194174 Histidine kinase, 636 HK, of staphylococcus aureus
02/27/2001US6194171 Also vectors, transformed cells; useful for expression in cells for the purposes of identifying agonists or antagonists of ataxin-2-binding protein function
02/27/2001US6194153 Methods for determining risk of developing alzheimer's disease by detecting mutations in the presenilin 1 (PS-1) gene
02/27/2001US6194142 Nucleotide sequences derived from the genome of retroviruses of the HIV-1, HIV-2, and SIV type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses
02/27/2001US6193980 Replication defective herpes simplex virus comprising heterologous inserts
02/22/2001WO2001013117A2 Proteins, genes and their use for diagnosis and treatment of breast cancer
02/22/2001WO2001012830A1 Adenoviral vectors including dna sequences encoding angiogenic inhibitors
02/22/2001WO2001012818A1 Neutral cerebral-sphingomyelinase
02/22/2001WO2001012815A1 Coxsackie virus-derived vector system for gene transfer
02/22/2001WO2001012811A1 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
02/22/2001WO2001012806A2 Odorant-binding human proteins fixing hydrophobic ligands: polypeptides and polynucleotides coding for said polypeptides and uses thereof
02/22/2001WO2001012805A1 Methods for diagnosis and treatment of human diseases including hypertension
02/22/2001WO2001012804A2 MODULATION OF OLIGONUCLEOTIDE CpG-MEDIATED IMMUNE STIMULATION BY POSITIONAL MODIFICATION OF NUCLEOSIDES
02/22/2001WO2001012803A2 Methods and compositions for restoring antibiotic susceptibility in glycopeptide-resistant enterococcus